Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × Injections × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 17 Myelodysplastic Syndromes 6 Leukemia, Myelomonocytic, Chronic 5 Myeloproliferative Disorders 3 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Monocytic, Acute 2 Advanced Solid Tumour 2 Thrombocythemia, Essential 1 Strabismus 1 Solid Tumor 1 Sarcoma 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Non-Squamous Non-small Cell Lung Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Sclerosis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia, Basophilic, Acute 1 Idiopathic Pulmonary Fibrosis 1 Hodgkin Disease 1 Emergence Delirium 1 Depression 1

Interventions

pertuzumab 2 Trastuzumab 2 tucatinib 1 pyrotinib 1 Paclitaxel 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡